Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Schizophrenia
100%
Gene-deficient Mice
100%
Glutaminase 1 (GLS1)
100%
Psychiatric Medication
100%
Latent Inhibition
100%
Hypoactivity
100%
Heterozygous Mice
44%
Amphetamine
22%
Presynaptic Modulation
22%
Pathophysiology of Schizophrenia
22%
Glutamine
22%
Glutamate
22%
Brain Regions
11%
Pathophysiology
11%
Schizophrenic Patients
11%
Potentiation
11%
Functional Imaging
11%
Dysregulated
11%
Hypometabolism
11%
Cerebral Blood Volume
11%
Glutamatergic Neurotransmission
11%
Antipsychotics
11%
Clozapine
11%
Ketamine
11%
Glutamate Transmission
11%
Glutamatergic Synaptic Transmission
11%
Prodromal
11%
Pharmacotherapy
11%
Behavioral Abnormalities
11%
Striatal Dopamine Release
11%
Knockdown
11%
Glutaminase Inhibition
11%
Subiculum
11%
Stimulatory Effect
11%
Preclinical Imaging
11%
Glutamatergic Transmission
11%
Glutamate Pathway
11%
Cortical Activation
11%
Psychotic
11%
Imaging Findings
11%
Associated Phenotypes
11%
Therapeutic Promises
11%
Global Reduction
11%
Neuroscience
Latent Inhibition
100%
Psychotomimetic
100%
Glutaminase
100%
Hypoactivity
100%
Glutamic Acid
80%
Synaptic Transmission
40%
Glutamine
40%
Presynaptic Modulation
40%
Amphetamine
40%
Subiculum
20%
Clozapine
20%
Ketamine
20%
Dopamine Release
20%
Functional Imaging
20%
Antipsychotic
20%
Drug Therapy
20%
Pharmacology, Toxicology and Pharmaceutical Science
Glutaminase
100%
Psychotomimetic
100%
Hypoactivity
100%
Glutamic Acid
80%
Pathophysiology
60%
Glutamine
40%
Amphetamine
40%
Antipsychotic
20%
Ketamine
20%
Clozapine
20%
Pharmacotherapy
20%
Biochemistry, Genetics and Molecular Biology
Glutaminase
100%
Latent Inhibition
100%
Glutamic Acid
80%
Glutamatergic
60%
Synaptic Transmission
40%
Glutamine
40%
Genetics
20%
Clozapine
20%
Dopamine Release
20%
Drug Therapy
20%
Antipsychotic
20%